IRES Track I: A U.S.-Ireland Partnership for an International Graduate Research Experience in Biopharmaceutical Processing

IRES 第一轨：美国-爱尔兰合作伙伴关系，提供生物制药加工方面的国际研究生研究经验

• 批准号: 2107401
• 负责人: Geoffrey Toner
• 金额: $ 30万
• 依托单位: Thomas Jefferson University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-12-01 至 2024-11-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2107401&HistoricalAwards=false
• 关键词: IRES; Track; U.S.; Ireland; Partnership

The U.S. economy is faced with unprecedented challenges in numerous industry sectors. These challenges underscore a compelling opportunity to prepare the next generation of biopharmaceutical scientists who are specially trained in a field that our world desperately needs. Despite the fact that international partnerships between U.S. and non-U.S.-based sites are often challenging to arrange, especially in the area of biomanufacturing, we have a unique opportunity to execute a Track 1 International Research Experience (IRES) that capitalizes on our existing collaboration between Thomas Jefferson University and Ireland’s National Institute for Bioprocessing Research and Training (NIBRT), a non-academic research enterprise. The program will provide a unique training and educational research experience in a world class facility, engage underrepresented minorities, and provide assistance to transition the participants to industry or advanced degree programs.Thomas Jefferson University proposes to engage its international training partner, the National Institute for Bioprocessing Research and Training (NIBRT) to enable global research in methodologies of bioanalytics and biomonitoring with the following goals: (1) Offer a specially selected cohort of students (N=6 each year) the opportunity to develop agile, analytical skills in biopharmaceutical process engineering with a prominent global leader so that they emerge as distinctively prepared. (2) Increase the inclusion of underrepresented minorities (URMs) in the life sciences and engineering through participation in biopharmaceutical process engineering and recruitment efforts. (3) Train and transition exceptionally prepared, highly competitive students into industry positions or advanced degree programs. Our long-term goals are to increase the workforce pipeline for the biopharmaceutical and vaccine industries, and foster U.S. manufacturing competitiveness in an area critically important to human health and national security. The biopharmaceutical industry is highly regulated and research and training opportunities at relevant sites are both difficult and costly. The meaningful relationship already in place between Philadelphia/Jefferson and NIBRT offers a powerful convergence of two thought leaders in establishing a novel and potentially transformative research training experience that capitalizes on our international exchange, existing curriculum, and world-class researchers and capabilities unmatched anywhere else on the globe. Furthermore, continued targeted efforts to engage URMs are critical to the evolution of the U.S.’s STEM workforce as the diversity of U.S. populations increase and we attempt to remain competitive in STEM fields. Finally, we intend to build this nascent international opportunity into a sustainable and long-term exchange in which U.S. and NIBRT trainees have global opportunities on either continent. In return, by securing this type of training and experiential learning, we will contribute significantly to a workforce that is desperately needed in the biomanufacturing industry and our findings will bolster the existing literature on the advantages of international STEM student training opportunities.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

在许多行业领域，美国经济面临着前所未有的挑战。这些挑战为一个令人信服的机会做好了准备，以准备下一代生物制药科学家，他们在我们的世界迫切需要的领域受过专门训练。尽管事实是，美国和非U.S. S.S.S.S. S.之间的国际伙伴关系通常受到挑战，尤其是在生物制造领域，但我们有一个独特的机会，可以执行赛道1国际研究经验（IRES），该研究经验（IRES）利用了我们在托马斯·杰斐逊大学与爱尔兰国家与爱尔兰国家生物学研究所研究和培训（NIBRT）（NIBRT）（NIBRT）的现有合作，一项非 - ac ad empriase intrapermactimporiase interprise。 The program will provide a unique training and educational research experience in a world class facility, engage underrepresented minorities, and provide assistance to transition the participants to industry or advanced degree programs.Thomas Jefferson University proposals to engage its international training partner, the National Institute for Bioprocessing Research and Training (NIBRT) to enable global research in methods of bioanalytics and biomonitoring with the following goals: (1) Offer a specially selected cohort of学生（每年n = 6个）有机会在生物制药过程工程中发展敏捷的分析技能，并以全球著名的全球领导者的形式发展为独特的准备。 （2）通过参与生物制药工程工程和招聘工作，增加了人生科学和工程中代表性不足的少数民族（URM）的包含。 （3）训练和过渡精心准备的，竞争激烈的学生进入行业职位或高级学位课程。我们的长期目标是增加生物制药和疫苗行业的劳动力管道，并在对人类健康和国家安全至关重要的领域中培养美国制造业的竞争力。生物制药行业受到高度监管，相关站点的研究和培训机会既困难又昂贵。费城/杰斐逊和Nibrt之间已经建立了有意义的关系，这为两位思想领袖提供了有力的融合，以建立一种新颖而潜在的变革性研究培训经验，该经验利用了我们的国际交流，现有课程以及世界级的研究人员以及全球其他任何地方都无与伦比的能力。此外，随着美国人口的多样性的增加，持续的有针对性的努力使参与URM的努力对于美国的STEM劳动力的发展至关重要，我们试图在STEM领域保持竞争力。最后，我们打算将这个新兴的国际机会建立在可持续和长期的交流中，在这种交流中，美国和nbibrt训练者在持续方面都有全球机会。作为回报，通过确保这种类型的培训和经验学习，我们将为生物制造业迫切需要的劳动力做出重大贡献，我们的发现将加强有关国际STEM学生培训机会优势的现有文献。该奖项反映了NSF的法规任务，并通过对基金会的知识优点进行评估而被视为珍贵的支持Crice和广泛的critia critia criter critia critia criter critia criter critia criter critia criter critia criteria criter critia cripia cripitia aviews奖。